image
Enanta Pharmaceuticals, Inc. ENTA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.53
-5.92 %
$ 202 M
Market Cap
-1.75
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-09-30 -8.07% -9.91% -10.79%
Annual Report FY 10-K 2022-09-30 -11.24% -54.13% -13.02%
Annual Report FY 10-K 2021-09-30 -20.74% -118.41% -163.15%
Annual Report FY 10-K 2020-09-30 -40.31% -77.98% -113.34%
Annual Report FY 10-K 2019-09-30 -0.69% -35.54% -58.41%
Annual Report FY 10-K 2018-09-30 100.97% 306.30% 258.85%
Annual Report FY 10-K 2017-09-30 16.48% -18.26% -20.19%
Annual Report FY 10-K 2016-09-30 -45.13% -72.57% -75.16%
Annual Report FY 10-K 2015-09-30 236.98% 129.37% 553.93%
Annual Report FY 10-K 2014-09-30 48.94% 257.72% 110.27%
Annual Report FY 10-K 2013-09-30 -23.15% -55.01% -57.59%
Annual Report FY 10-K 2012-09-30 -0.42% -8.20% -15.85%
Annual Report FY 10-K 2011-09-30 83.99% 194.91% 264.43%
Annual Report FY 10-K 2010-09-30 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-06-30 -4.88% 42.00% 34.12%
Quarterly Report Q2 8-K 2024-03-31 -4.16% 17.26% 16.95%
Quarterly Report Q1 8-K 2023-12-31 -23.67% -15.25% -16.24%
Quarterly Report Q4 8-K 2023-09-30 -6.82% -6.68% -14.72%
Quarterly Report Q3 8-K 2023-06-30 -3.01% -23.23% -12.82%
Quarterly Report Q2 8-K 2023-03-31 -4.92% -12.96% -16.56%
Quarterly Report Q1 8-K 2022-12-31 -14.70% 3.75% 1.30%
Quarterly Report Q4 8-K 2022-09-30 -13.82% -7.11% 19.80%
Quarterly Report Q3 8-K 2022-06-30 -9.92% -31.95% 3.86%
Quarterly Report Q2 8-K 2022-03-31 -7.03% -51.22% -13.96%
Quarterly Report Q1 8-K 2021-12-31 -12.90% -261.61% -147.25%
Quarterly Report Q4 8-K 2021-09-30 -0.24% 16.16% -70.48%
Quarterly Report Q3 8-K 2021-06-30 15.93% -68.41% -48.11%
Quarterly Report Q2 8-K 2021-03-31 -27.11% -267.11% -150.11%
Quarterly Report Q1 8-K 2020-12-31 -39.62% -61.95% -95.56%
Quarterly Report Q4 8-K 2020-09-30 -53.95% -319.24% -307.62%
Quarterly Report Q3 8-K 2020-06-30 -57.96% -202.74% -608.58%
Quarterly Report Q2 8-K 2020-03-31 -30.31% -144.87% -810.66%
Quarterly Report Q1 8-K 2019-12-31 -24.78% -48.32% -53.79%
Quarterly Report Q4 8-K 2019-09-30 -23.65% -66.48% -81.33%
Quarterly Report Q3 8-K 2019-06-30 -22.52% -65.32% -83.41%
Quarterly Report Q2 8-K 2019-03-31 -10.03% -66.99% -7.73%
Quarterly Report Q1 8-K 2018-12-31 83.38% 122.45% 93.75%
Quarterly Report Q4 8-K 2018-09-30 -11.49% -24.89% -36.55%
Quarterly Report Q3 8-K 2018-06-30 662.38% 340.78% 272.44%
Quarterly Report Q2 8-K 2018-03-31 391.67% 332.84% 277.35%
Quarterly Report Q1 8-K 2017-12-31 265.83% 334.80% 304.04%
Quarterly Report Q4 8-K 2017-09-30 491.29% 2125.97% 1852.02%
Quarterly Report Q3 8-K 2017-06-30 -46.27% -683.09% -1105.60%
Quarterly Report Q2 8-K 2017-03-31 -31.11% -227.78% -1582.48%
Quarterly Report Q1 8-K 2016-12-31 -78.50% -19.02% -19.80%
Quarterly Report Q4 8-K 2016-09-30 -10.93% -31.00% -84.35%
Quarterly Report Q3 8-K 2016-06-30 20.51% -44.50% -63.95%
Quarterly Report Q2 8-K 2016-03-31 -77.33% -5.72% -1.16%
Quarterly Report Q1 8-K 2015-12-31 -37.49% -37.66% -49.30%
Quarterly Report Q4 8-K 2015-09-30 446.68% 215.27% 168.98%
Quarterly Report Q3 8-K 2015-06-30 -72.42% -95.17% -95.12%
Quarterly Report Q2 8-K 2015-03-31 2555.88% 652.62% 1047.16%
Quarterly Report Q1 8-K 2014-12-31 8578.39% 882.29% 1386.60%
Quarterly Report Q4 8-K 2014-09-30 95.48% -13.48% -13.30%
Quarterly Report Q3 8-K 2014-06-30 2450.09% 1309.59% 935.21%
Quarterly Report Q2 8-K 2014-03-31 80.60% -38.78% -28.14%
Quarterly Report Q1 8-K 2013-12-31 -96.79% -24.46% -24.91%
Quarterly Report Q4 8-K 2013-09-30 -27.40% -9.65% -12.76%
Quarterly Report Q3 8-K 2013-06-30 -35.13% -18.19% -18.42%
Quarterly Report Q2 8-K 2013-03-31 -96.73% -11.68% -12.47%
Quarterly Report Q1 8-K 2012-12-31 3659.65% 795.06% 788.53%
Quarterly Report Q4 8-K 2012-09-30 0.00% -1.58% -0.92%
Quarterly Report Q3 8-K 2012-06-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2012-03-31 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2011-12-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2011-09-30 0.00% 0.00% 0.00%